Clinical Trial

Microbiological Effect of 0.12% Chlorhexidine Digluconate and 0.05% Cetylpyridinium Chloride vs Probiotics (Lactobacillus Reuteri Prodentis) on Porphyromonas Gingivalis.

Active, Not Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
This randomized non-inferiority clinical trial aims to evaluate the microbiological effect of 0.12% chlorhexidine and 0.05% cetylpyridinium vs. probiotics (Lactobacillus reuteri Prodentis) on Porphyromonas gingivalis in patients with periodontal disease and diabetes mellitus in Colima, where molecular biology tests such as qPCR will be performed at the end, before and after treatment in each of the groups.
Trial Details
NCT Number NCT07489924
Lead Sponsor Universidad de Colima
Collaborators: Secretaria de Salud, Mexico
Conditions Periodontal Diseases, Diabetes Mellitus Type 2
Enrollment 20 participants
Start Date 2023-01-08
Primary Completion 2025-07-31 (estimated)
Study Completion 2026-07-31 (estimated)
Updated on ClinicalTrials.gov 2026-03-24